-

Shareholder Alert: Robbins LLP Investigates TransUnion (TRU) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating TransUnion (NYSE: TRU) to determine whether certain TransUnion officers and directors violated securities laws and breached fiduciary duties to shareholders. TransUnion is a well-known credit reporting agency, which describes itself as a “leading global information and insights company that makes trust possible between businesses and consumers, working to help people around the world access opportunities that can lead to a higher quality of life.”

If you would like more information about our investigation of TransUnion's misconduct, click here.

TransUnion (TRU) Violated the Consent Order Imposed by the Consumer Federal Protection Bureau

In 2017, the Consumer Financial Protection Bureau ("CFPB") imposed a law enforcement order on TransUnion to stop the Company from engaging in deceptive marketing regarding its credit scores and address other issues involving credit-related products (the "Consent Order"). Terms of the Consent Order required TransUnion and its subsidiaries to pay $13.9 million in restitution and $3 million in civil penalties. The Consent Order also provided that TransUnion had to submit a comprehensive compliance plan designed to ensure that the Company’s advertising practices complied with all applicable federal laws and the terms of the Consent Order.

Despite the existence of the Consent Order, on April 12, 2022, the CFPB announced that it was filing a lawsuit against TransUnion, TransUnion Interactive, Inc., TransUnion, LLC, and former key executive John Danaher for violating the Consent Order. CFPB stated in a press release that “TransUnion is an out-of-control repeat offender that believes it is above the law. …TransUnion’s leadership is either unwilling or incapable of operating its businesses lawfully.” Moreover, the Chairman of the House Select Subcommittee on the Coronavirus Crisis is concerned that TransUnion violated the Fair Credit Reporting Act for failing to respond to consumer complaints during the pandemic. Thus, TransUnion could face another investigation resulting from its disregard of its obligations to consumers.

TransUnion (TRU) shareholders have legal options. If you own shares of TransUnion or have incurred a recent significant loss in the stock, contact us for more information about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against TransUnion settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:TRU

Release Summary
TransUnion (TRU) Violated the Consent Order Imposed by the Consumer Federal Protection Bureau
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Masonite International Corporation (k/n/a Owens Corning's Doors) Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all sellers of Masonite International Corporation (NYSE: DOOR) (k/n/a Owens Corning's Doors) common stock between June 5, 2023 and February 8, 2024. Masonite is a leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for the residential and non-residential building construction markets’ new construction and repair, renovation and re...
Back to Newsroom